Esthesioneuroblastoma is an uncommon tumor of the olfactory neuroepithelium with most studies based on the Caucasian population. This retrospective analysis of esthesioneurolastomas in an Asian population over a 13 year period aims to compare the characteristics of this tumor and treatment outcomes in an Asian population with that of overseas institutions. In our study, there are significant differences compared to that of the Caucasian population for Asians with esthesioneuroblastomas. The lack of bimodal distribution and male predilection suggest a possible genetic difference between esthesioneuroblastomas between the Asian and Caucasian population. Craniofacial resection is a safe operation for esthesioneuroblastomas with good survivability.
In our series of craniofacial resections in Asian patients, we have a significantly higher incidence of esthesioneuroblastomas than the Caucasian population 2 . For patients with esthesioneuroblastomas, there was a male predilection as opposed to a female predisposition. There was also a lack of the bimodal age distribution classically described for esthesioneuroblastomas. We seek a peak in the 6 th decade and no peak in the 2 nd decade as classically described in the Caucasian population 3 . A multi-center study within Asia would be helpful in achieving greater statistical significance in the study of this tumor. Despite the high rate of recurrences, patients with esthesioneuroblastoms have a fairly good prognosis. There was no tumor related mortality in this study, showing that with appropriate treatment, patients can have good survivability.
This was a retrospective study of all anterior skull base tumors requiring craniofacial resections performed Singapore General Hospital from January 1997-January 2010. We focused our data analysis on patients diagnosed with esthesioneuroblastoms as this was the commonest indication for esthesioneuroblastomas. All patients with esthesioneuroblastomas were then treated with a dual modality of craniofacial resection and adjuvant radiotherapy.
Esthesioneuroblastomas are more common in Asians with different biologic behavior. Lifelong surveillance is important as recurrences can occur many years later, Craniofacial resection for esthesioneuroblastomas is a safe operation and patients can have good survivability after operations. Esthesioneuroblastoma is an uncommon tumor of the olfactory epithelium. With a reported incidence of 3% for sinonasal neoplasms, there has been more than 1000 cases reported in the literature mainly as single case reports or case series 1 . In our centre, the largest tertiary hospital in Singapore, which sees predominantly Asian patients for craniofacial resections, we note significant differences between our experience with esthesioneuroblastomas and the published ones.
INTRODUCTION METHODS AND MATERIALS
Over a period of 13 years, a total of 48 patients underwent craniofacial resections. The majority of our patients had esthesioneuroblastomas (50%) (table 1). For patients with esthesioneuroblastomas. There was a peak incidence in the 6 th decade of life (figure 1) and this happened more commonly in males (62%). The top 3 symptoms were epistaxis, blocked nose and rhinorrhea. Recurrences occurred in 12 patients out of the 24 patients with esthesioneuroblastomas . Most occurred within the first year of diagnosis with some occurring more than 5 years after the initial diagnosis. Post-operative complication rate occurred in 37% of patients (tables 2 and 3). Post-operative mortality occurred in 1 patient (2%) secondary to an acute myocardial infarct. The other 2 causes of were unrelated to the primary disease. The overall 10 year survival rate 86%
